Repros Therapeutics Inc. Presents Androxal® and Proellex® Clinical Updates at the Lazard Capital Markets 9th Annual Healthcare Conference

THE WOODLANDS, Texas, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced the Company will present clinical updates for both its Androxal® and Proellex® programs this Wednesday, November 14th, at 8 a.m. Eastern time. Due to the format of the conference, the number of slides presented will be abbreviated. The Company is not webcasting the presentation but has the full slide presentation available on its website, www.reprosrx.com. The following significant clinical developments will be discussed in the presentation: